
Health & Fitness8.5
Massive hope for pancreatic cancer pill after trial saw tumours vanish
BBC Health · Nov 20, 2026
A new oral drug called daraxonrasib has shown promising results in early trials for pancreatic cancer, with some patients experiencing significant tumor shrinkage and even complete disappearance. The study highlights the potential of a pill-based treatment for a disease that traditionally has very poor outcomes. If these findings are confirmed, it could represent a major shift in how pancreatic cancer is managed.
Why it matters
Pancreatic cancer has one of the lowest survival rates, and effective treatments are scarce; a successful oral therapy could improve patient quality of life and survival prospects while simplifying treatment delivery.
Key takeaways
- Daraxonrasib, an oral pill, caused tumors to shrink in trial participants
- Some patients saw complete tumor disappearance
- Pancreatic cancer currently has limited treatment options and poor prognosis
- The trial is early‑phase but indicates a potentially transformative approach
- Success could lead to larger studies and eventual regulatory approval